日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tumor metabolic plasticity in therapy resistance: from the Warburg effect to mitochondrial hijacking

肿瘤代谢可塑性在治疗耐药中的作用:从瓦博格效应到线粒体劫持

Tzeng, Yen-Dun Tony; Raj, Emmanuel Naveen; Cheng, Shih-Hsuan; Yong, Su-Boon; Lin, Shih-Chieh; Peng, Ren-Wang; Li, Chia-Jung

Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma

更正:从头嘧啶合成是NF2缺陷型间皮瘤的伴随代谢脆弱性

Xu, Duo; Gao, Yanyun; Liu, Shengchen; Yin, Shiyuan; Hu, Tong; Deng, Haibin; Zhang, Tuo; Hegedüs, Balazs; Marti, Thomas M; Dorn, Patrick; Liang, Shun-Qing; Schmid, Ralph A; Peng, Ren-Wang; Shu, Yongqian

Ubiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer.

泛醌介导的线粒体相关铁死亡抑制是乳酸脱氢酶 B 在癌症治疗中的一种可靶向功能

Deng Haibin, Zhao Liang, Ge Huixiang, Gao Yanyun, Fu Yan, Lin Yantang, Masoodi Mojgan, Losmanova Tereza, Medová Michaela, Ott Julien, Su Min, Wang Wenxiang, Peng Ren-Wang, Dorn Patrick, Marti Thomas Michael

De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.

NF2 缺陷型间皮瘤中嘧啶从头合成是一种伴随的代谢脆弱性

Xu Duo, Gao Yanyun, Liu Shengchen, Yin Shiyuan, Hu Tong, Deng Haibin, Zhang Tuo, Hegedüs Balazs, Marti Thomas M, Dorn Patrick, Liang Shun-Qing, Schmid Ralph A, Peng Ren-Wang, Shu Yongqian

Distinct molecular subtypes of KRAS(G12C)-mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategies

KRAS(G12C)突变型肺腺癌的不同分子亚型:对临床结果、肿瘤微环境和治疗策略的深入探讨

Yang, Haitang; Zhu, Anshun; Niu, Yongliang; Ma, Wenyan; Xu, Ke; Jia, Yunxuan; Xu, Weijiao; Zhao, Baicheng; Zhang, Enshuo; Jia, Jiaying; Liang, Shunqing; Dorn, Patrick; Liu, Gang; Peng, Ren-Wang; Yao, Feng

Transitional CXCL14(+) cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma

过渡型 CXCL14(+) 癌相关成纤维细胞增强肿瘤转移并赋予 EGFR-TKI 耐药性,揭示了肺腺癌对 filgotinib 的治疗敏感性

Xu, Weijiao; Yang, Haitang; Xu, Ke; Zhu, Anshun; Hall, Sean R R; Jia, Yunxuan; Zhao, Baicheng; Zhang, Enshuo; Liu, Gang; Xu, Jianlin; Marti, Thomas M; Peng, Ren-Wang; Dorn, Patrick; Niu, Yongliang; Pan, Xufeng; Zhang, Yajuan; Yao, Feng

Inhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma.

抑制 LDHB 可引发 DNA 损伤,并增加胸膜间皮瘤对顺铂的敏感性

Lin Yantang, Dubey Christelle, Losmanova Tereza, Yasmin Samuel Oevgü, Reymond Jean-Louis, Peng Ren-Wang, Deng Haibin, Dorn Patrick, Marti Thomas Michael

LDHB silencing enhances the effects of radiotherapy by impairing nucleotide metabolism and promoting persistent DNA damage.

LDHB 沉默通过损害核苷酸代谢和促进持续性 DNA 损伤来增强放射疗法的效果

Deng Haibin, Malsiu Fatlind, Ge Huixiang, Losmanova Tereza, Medová Michaela, Zamboni Nicola, Wang Wenxiang, Peng Ren-Wang, Tang Jinming, Dorn Patrick, Marti Thomas Michael

The role of LncRNA SNHG3 in human cancers

LncRNA SNHG3在人类癌症中的作用

Tang, Jinming; Su, Min; Xiao, Yuhang; Ou, Wei; Wang, Wenxiang; Peng, Ren-Wang; Wu, Zhining

Advancing cancer therapy: new frontiers in targeting DNA damage response

推进癌症治疗:靶向DNA损伤反应的新前沿

Qian, Jiekun; Liao, Guoliang; Chen, Maohui; Peng, Ren-Wang; Yan, Xin; Du, Jianting; Huang, Renjie; Pan, Maojie; Lin, Yuxing; Gong, Xian; Xu, Guobing; Zheng, Bin; Chen, Chun; Yang, Zhang